Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers Pricing

Legal

argenx Jobs | Formulate

Jobs
argenx

argenx Jobs

Belgium - Zwijnaarde

Biotechnology

argenx is a life sciences company focused on Antibody therapies.

84 open positions at argenx

View Full Profile

Program Director, Governance Forums

argenx

Posted 1mo ago

Remote

$212K - $292K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologyExecutive

H-1B · 1 FY23

Clinical Operations Development Lead

argenx

Posted 1mo ago

Remote

$212K - $292K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteClinical OperationsImmunologySenior

H-1B · 1 FY23

DT AI Platform Lead

argenx

Posted 1mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologySenior

H-1B · 1 FY23

Head of Specialized Sourcing

argenx

Posted 2mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyExecutive

H-1B · 1 FY23

Executive Assistant

argenx

Posted 2mo ago

Boston, MA, USA

$76K - $105K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyExecutive

H-1B · 1 FY23

Legal Counsel, Clinical Development

argenx

Posted 2mo ago

Remote

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteClinical DevelopmentImmunologyMID

H-1B · 1 FY23

Associate Director, Medical Writing

argenx

Posted 2mo ago

Remote

$164K - $226K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteMedical WritingImmunologyExecutive

H-1B · 1 FY23

Head of Rewards & Recognition, Developed Markets

argenx

Posted 2mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyExecutive

H-1B · 1 FY23

Team Lead Finance Operations (AP & FBS)

argenx

Posted 2mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

FinanceImmunologySenior

H-1B · 1 FY23

Toxicologist late stage clinical development and established Assets

argenx

Posted 3mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Clinical DevelopmentImmunologyMID

H-1B · 1 FY23

Digital Technology Business Lead - Research

argenx

Posted 3mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Research & DevelopmentImmunologySenior

H-1B · 1 FY23

DT Strategic Partnerships Lead

argenx

Posted 3mo ago

Remote

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteBusiness DevelopmentImmunologySenior

H-1B · 1 FY23

Digital Technology Product Owner, US Market Access

argenx

Posted 3mo ago

Boston, MA, USA

$156K - $215K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

CommercialImmunologyMID

H-1B · 1 FY23

Digital Technology Product Owner, US HCP Experience

argenx

Posted 3mo ago

Boston, MA, USA

$184K - $253K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Head of U.S. Regulatory Advertising & Promotion and Strategic Commercialization

argenx

Posted 3mo ago

Remote

$268K - $369K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteRegulatory AffairsImmunologyExecutive

H-1B · 1 FY23

Principal Scientist Bioanalytics

argenx

Posted 4mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Research & DevelopmentImmunologySenior

H-1B · 1 FY23

Biomarker Biostatistics Lead

argenx

Posted 5mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Data ScienceImmunologySenior

H-1B · 1 FY23

Director of Medical Writing

argenx

Posted 6mo ago

Remote

$212K - $292K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteMedical WritingImmunologyExecutive

H-1B · 1 FY23

Reporting & Insights Lead

argenx

Posted 6mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologySenior

H-1B · 1 FY23

Clinical Operations Development Lead

argenx

Posted 6mo ago

Remote

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteClinical OperationsImmunologySenior

H-1B · 1 FY23

Company Overview

Active Jobs

Pipeline Programs

Drug Products

Clinical Trials

View Full Company Profile

Therapeutic Areas

Neurology Immunology Oncology

Links

Company Website Careers Page

Hematology

Rare Diseases